social digital currency- Top Top stories

The net purchase of southbound funds exceeded 10 billion yuan.The retail price of refined oil may end up stranded. According to calculation, as of the seventh working day on December 13th, the average price of reference crude oil varieties was 70.58 USD/barrel, with a change rate of -0.87%, and the corresponding domestic retail price of gasoline and diesel should be lowered by 40 yuan/ton. At 24: 00 on December 18th, it is the last price adjustment window of the retail price in 2024, so the retail price is likely to end stranded. By December 13th, 2024, the domestic retail price of gasoline and diesel had experienced "9 up, 9 down and 6 stranded". After the fluctuation offset, gasoline and diesel (standard products) were reduced by 115 yuan/ton and 125 yuan/ton respectively. (Jin Lianchuang)Beijing Stock Exchange plans to carry out the fifth network-wide test of trading support platform optimization tomorrow. On December 13th, the office of Beijing Stock Exchange and the office of National Stock Transfer Company issued a notice to carry out the fifth network-wide test of trading support platform optimization on December 14th. The participating institutions are Beijing Stock Exchange, National Stock Transfer Company, China Clearing, Shenzhen Stock Connect, securities companies, fund companies and information providers.

Singapore Straits Times Index closed at 3,810.35.Helen Piano's profit distribution plan for the first three quarters: it is planned to distribute 0.32 yuan for 10 shares, and Helen Piano (300329) released the profit distribution plan for the first three quarters of 2024 on the evening of December 13, and it is planned to distribute a cash dividend of 0.32 yuan (including tax) to all shareholders for every 10 shares, with an estimated cash dividend of 8,092,400 yuan.Borui Medicine: Carboprost injection is planned to win the bid for the national centralized drug procurement. Borui Medicine announced that in the tenth batch of national centralized drug procurement in which Borui Pharmaceutical, a wholly-owned subsidiary, participated, carboprost tromethamine injection is planned to win the bid. This product is mainly used for 13-20 weeks pregnant abortion and postpartum hemorrhage. The specification is 1 ml: 250μ g, and the proposed bid price is 16.96 yuan/piece. In the first year, the agreed purchase base is 220,400 pieces, which are mainly supplied to Henan, Hubei, Guangxi, Shaanxi, Gansu, Ningxia and other provinces. If the contract is finally selected and signed, it will help the product to quickly open the domestic market and enhance the market share and brand influence of the company. The product obtained the drug registration certificate in March 2024, and has not yet generated sales revenue.

Yiling Pharmaceutical Co., Ltd.: The application for clinical trial of Lianhua Yuping Granule was approved, and Yiling Pharmaceutical announced that Beijing Yiling, a wholly-owned subsidiary, received the Notice of Approval for Clinical Trial of Drugs approved and issued by National Medical Products Administration on December 12, 2024, and agreed to carry out clinical trial of Lianhua Yuping Granule for qi deficiency syndrome of common cold.Pacific Securities: Goldwind Technology's performance is expected to achieve rapid growth, with the first "buy" rating. Pacific Securities Research Report pointed out that with the profit recovery of wind turbine business and the contribution of wind farm investment and development and wind power service business, Goldwind Technology's (002202.SZ) performance is expected to achieve rapid growth. The first coverage gives a "buy" rating. Goldwind Technology has ranked first in the domestic wind power market for 13 consecutive years since 2011; However, in recent years, under the strong competitive pressure of wind turbine enterprises after the second line, their market share has declined. In the future, with the increase of market concentration, Goldwind Technology, as a leader, is expected to increase its share. At the end of the third quarter of 2024, the company's external order volume was 41.38GW, and sufficient in-hand order volume supported its share increase.Spring Airlines: In November, the company's passenger transport capacity investment (in terms of available seat kilometers) increased by 10.36% year-on-year and decreased by 9.93% quarter-on-quarter; Passenger turnover (in terms of revenue passenger kilometers) increased by 12.73% year-on-year and decreased by 9.92% quarter-on-quarter; The load factor increased by 1.90% year-on-year and 0.02% quarter-on-quarter.